| Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice M Volta, DA Beccano-Kelly, SA Paschall, S Cataldi, SE MacIsaac, ... Elife 6, e28377, 2017 | 85 | 2017 |
| Altered dopamine release and monoamine transporters in Vps35 p. D620N knock-in mice S Cataldi, J Follett, JD Fox, I Tatarnikov, C Kadgien, EK Gustavsson, ... npj Parkinson's Disease 4 (1), 27, 2018 | 64 | 2018 |
| Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression W Gesztes, C Schafer, D Young, J Fox, J Jiang, Y Chen, HC Kuo, ... Scientific reports 12 (1), 5404, 2022 | 12 | 2022 |
| Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized … W Al Zoughbi, J Fox, S Beg, E Papp, E Hissong, K Ohara, L Keefer, ... The oncologist 26 (11), e1971-e1981, 2021 | 11 | 2021 |
| Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition CA Kadgien, A Kamesh, AJ Milnerwood Molecular brain 14 (1), 143, 2021 | 11 | 2021 |
| DNAJC13 p. Asn855Ser, implicated in familial parkinsonism, alters membrane dynamics of sorting nexin 1 J Follett, JD Fox, EK Gustavsson, C Kadgien, LN Munsie, LP Cao, ... Neuroscience Letters 706, 114-122, 2019 | 8 | 2019 |
| Altered dopamine release and monoamine transporters in Vps35 p. D620N knock-in mice. NPJ Park. Dis. 4, 27 S Cataldi, J Follett, JD Fox, I Tatarnikov, C Kadgien, EK Gustavsson, ... | 7 | 2018 |
| Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab H Alnajar, H Ravichandran, AF Rendeiro, K Ohara, W Al Zoughbi, ... Molecular Case Studies 8 (3), a006151, 2022 | 5 | 2022 |
| Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons SJF Cronin, W Yu, A Hale, S Licht-Mayer, MJ Crabtree, JA Korecka, ... bioRxiv, 2023 | 2 | 2023 |
| RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses EK Gustavsson, J Follett, J Trinh, SK Barodia, R Real, Z Liu, ... The Lancet Neurology, 2024 | 1 | 2024 |
| Comprehensive liquid biopsy profiling enabled by PGDx elio plasmacomplete to facilitate precision oncology through decentralized access to testing KC Valkenburg, V Caropreso, J Fox, C Gault, A Georgiadis, KM Gerding, ... Cancer Research 82 (12_Supplement), 72-72, 2022 | 1 | 2022 |
| Clinical validity of post-surgery circulating tumor DNA testing in stage III colon cancer patients treated with adjuvant chemotherapy: The PROVENC3 study CR Alarcon, A Georgiadis, IA Franken, H Wang, SC van Nassau, ... Cancer Research 84 (6_Supplement), 6559-6559, 2024 | | 2024 |
| A pathogenic variant in RAB32 causes autosomal dominant Parkinsons disease and activates LRRK2 kinase EK Gustavsson, J Follett, J Trinh, SK Barodia, R Real, Z Liu, ... medRxiv, 2024.01. 17.24300927, 2024 | | 2024 |
| Analytical Validation of PGDx elio Plasma Focus Dx to Facilitate Precision Oncology through Decentralized Liquid Biopsy for Solid Tumor Profiling J Fox, T Watkins, P Gu, C Ganey, C Maddox, P McGregor, AA Georgiadis, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S116-S116, 2023 | | 2023 |
| Detecting Molecular Residual Disease through Integrated Tumor Tissue, Germline, and Plasma Whole-Genome Sequencing Analyses A Georgiadis, D Riley, J White, C Greco, L Cox, J Fox, K Victor, ... JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S135-S135, 2023 | | 2023 |
| Surface GluA1 and glutamatergic transmission are increased in cortical neurons of a VPS35 D620N knock-in mouse model of parkinsonism and altered by LRRK2 kinase inhibition CA Kadgien, A Kamesh, J Khinda, LP Cao, J Fox, MJ Farrer, ... bioRxiv, 2021.01. 18.427223, 2021 | | 2021 |
| DNAJC13 in Parkinson's disease; characterization of the p. N855S knock-in mouse model J Follett, J Fox, E Gustavsson, M Farrrer MOVEMENT DISORDERS 34, S723-S723, 2019 | | 2019 |
| Racial/ethnic differences in prostate cancer genomic alterations A Dobi, G Petrovics, SH Tan, H Li, D Young, C Schafer, J Fox, K Babcock, ... Cancer Research 78 (13_Supplement), 5352-5352, 2018 | | 2018 |
| Novel genomic alterations in renal medullary carcinoma tumors J Fox, D Young, Y Song, HC Hu, A Soltis, MD Wilkerson, CL Dalgard, ... Cancer Research 78 (13_Supplement), 5354-5354, 2018 | | 2018 |
| Endosomal Tra c And Glutamate Synapse Activity Are Increased In VPS35 D620N Mutant Knock-In Mouse Neurons, And Resistant To LRRK2 Kinase Inhibition C Kadgien, A Kamesh, J Khinda, LP Cao, J Fox, MJ Farrer, A Milnerwood | | |
